Immunogen's $6,220 ovarian cancer drug to be shipped within days
(Reuters) - Drugmaker Immunogen said on Tuesday it will sell its newly approved ovarian cancer drug at a list price of $6,220 per vial and start shipp...
Source: whbl.com
Stay updated with breaking news from Drugmaker Immunogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) - Drugmaker Immunogen said on Tuesday it will sell its newly approved ovarian cancer drug at a list price of $6,220 per vial and start shipp...